174 related articles for article (PubMed ID: 6601552)
1. Complement activation by antibodies to Sm in systemic lupus erythematosus.
Sabharwal UK; Fong S; Hoch S; Cook RD; Vaughan JH; Curd JG
Clin Exp Immunol; 1983 Feb; 51(2):317-24. PubMed ID: 6601552
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus.
Yasuma M; Takasaki Y; Matsumoto K; Kodama A; Hashimoto H; Hirose S
J Rheumatol; 1990 Apr; 17(4):469-75. PubMed ID: 2348425
[TBL] [Abstract][Full Text] [Related]
3. Nonprecipitating IgG or IgM anti-Sm antibody: clinical significance and changes in immunoglobulin class.
Tsuzaka K; Ogasawara T; Tojo T; Mimori T; Satoh M; Homma M
J Rheumatol; 1993 May; 20(5):822-30. PubMed ID: 7687702
[TBL] [Abstract][Full Text] [Related]
4. Purification of the Sm nuclear autoantigen. Detection and clinical significance of IgM antibody.
Pollard KM; Tan EM
Clin Exp Immunol; 1985 Jun; 60(3):586-96. PubMed ID: 4017287
[TBL] [Abstract][Full Text] [Related]
5. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.
Eisenberg RA; Dyer K; Craven SY; Fuller CR; Yount WJ
J Clin Invest; 1985 Apr; 75(4):1270-7. PubMed ID: 3872886
[TBL] [Abstract][Full Text] [Related]
6. Antibody class differences are detected in anti-nRNP and anti-Sm antibodies directed against distinct antigen subunits.
Williams DG; Stocks MR; Charles PJ; Maini RN
Rheumatol Int; 1986; 6(4):189-92. PubMed ID: 3491411
[TBL] [Abstract][Full Text] [Related]
7. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
Mahler M; Fritzler MJ; Blüthner M
Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
[TBL] [Abstract][Full Text] [Related]
8. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus.
López-Longo FJ; Monteagudo I; González CM; Moreno AC; Rodríguez Mahou M; Grau R; Carreño L
J Rheumatol; 1998 Sep; 25(9):1743-9. PubMed ID: 9733455
[TBL] [Abstract][Full Text] [Related]
9. Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens.
Field M; Williams DG; Charles P; Maini RN
Ann Rheum Dis; 1988 Oct; 47(10):820-5. PubMed ID: 3143318
[TBL] [Abstract][Full Text] [Related]
10. Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay.
Mahler M; Stinton LM; Fritzler MJ
Clin Diagn Lab Immunol; 2005 Jan; 12(1):107-13. PubMed ID: 15642993
[TBL] [Abstract][Full Text] [Related]
11. Differential induction of lupus associated antinuclear antibodies in MRL mice by monoclonal anti-Sm antibodies.
Stocks MR; Williams DG; Maini RN
Clin Exp Immunol; 1987 Mar; 67(3):492-9. PubMed ID: 3496996
[TBL] [Abstract][Full Text] [Related]
12. Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice.
Elkon KB; Bonfa E; Llovet R; Eisenberg RA
J Immunol; 1989 Sep; 143(5):1549-54. PubMed ID: 2760462
[TBL] [Abstract][Full Text] [Related]
13. Complement-activating abilities of defined antinuclear antibodies.
Kanayama Y; Peebles C; Tan EM; Curd JG
Arthritis Rheum; 1986 Jun; 29(6):748-54. PubMed ID: 3487323
[TBL] [Abstract][Full Text] [Related]
14. Cellular control of antinuclear antibody production. Anti-dsDNA and anti-Sm plaque forming cells in SLE patients and normal individuals.
Weill BJ; Heavey AC; Evans J; Schur PH
Clin Exp Rheumatol; 1985; 3(1):39-47. PubMed ID: 3884204
[TBL] [Abstract][Full Text] [Related]
15. The fine specificity of IgG antiguanosine antibodies in systemic lupus erythematosus.
Yee WS; Weisbart RH
Clin Immunol Immunopathol; 1985 Aug; 36(2):161-7. PubMed ID: 3874031
[TBL] [Abstract][Full Text] [Related]
16. Benign monoclonal gammopathy with IgG anti-DNA, anti-Sm and anti-F(ab')2 activity.
Williams RC; Malone CC; Silvestris F; Nickerson KG
Clin Exp Rheumatol; 1997; 15(1):33-8. PubMed ID: 9093770
[TBL] [Abstract][Full Text] [Related]
17. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
Levo Y; Lotan C
Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
[No Abstract] [Full Text] [Related]
18. Anti-nRNP and anti-Sm antibodies.
Sharp GC
Arthritis Rheum; 1982 Jul; 25(7):757-60. PubMed ID: 6980651
[No Abstract] [Full Text] [Related]
19. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
Molden DP; Suzuki H; Nakamura RM
Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
[TBL] [Abstract][Full Text] [Related]
20. Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.
Milgrom H; Curd JG; Kaplan RA; Müller-Eberhard HJ; Vaughan JH
J Immunol; 1980 Jun; 124(6):2780-5. PubMed ID: 7373050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
